世界の留置カテーテル市場の規模、シェア、トレンド分析レポート – 業界の概要と2032年までの予測

留置カテーテル市場分析

留置カテーテル市場は、膀胱障害、腎不全、長期カテーテル挿入を必要とする神経疾患などの慢性疾患の増加により、大幅な成長を遂げています。カテーテル技術の進歩は、安全性、快適性、感染予防の向上に重点を置いたイノベーションにより、この拡大に重要な役割を果たしています。現代のカテーテルは、抗菌コーティング、生体適合性の向上、カテーテル関連尿路感染症（CAUTI）のリスクを軽減するシリコンベースの素材を特徴としています。たとえば、圧力を監視し、潜在的な閉塞を検出し、患者の転帰を改善し、合併症を予防するために、センサーとスマートテクノロジーを統合したカテーテルが開発されています。病院と在宅医療の両方の環境でカテーテルの需要が高まっているのは、世界的な人口の高齢化と泌尿器科および術後ケアの意識の高まりによるものです。北米は医療水準の高さから引き続き市場を支配していますが、アジア太平洋地域は医療インフラの整備と泌尿器疾患の有病率の向上により、最も急速な成長が見込まれています。市場は、規制基準や、ユーザーフレンドリーでより効果的なカテーテル ソリューションの開発を目的とした継続的な研究の影響も受けます。

留置カテーテル市場規模

世界の留置カテーテル市場規模は、2024年に175万米ドルと評価され、2032年には325万米ドルに達すると予測されており、2025年から2032年の予測期間中に7.98%のCAGRで成長すると見込まれています。市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、Data Bridge Market Researchがまとめた市場レポートには、詳細な専門家分析、患者の疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

留置カテーテル市場の動向

「抗菌・抗感染コーティングの採用拡大」

留置カテーテル市場における注目すべき傾向として、カテーテル関連尿路感染症（CAUTI）のリスクを軽減し、患者の安全性を高めることを目的とした抗菌および抗感染コーティングの採用が増えていることが挙げられます。銀合金コーティングや親水性コーティングなどのコーティング技術の革新は、細菌のコロニー形成やバイオフィルム形成を最小限に抑える効果があることから注目を集めています。たとえば、銀合金コーティングを施したカテーテルは、従来のカテーテルと比較して感染率が大幅に低下することが実証されています。この傾向は、CAUTIに関連する合併症に対する認識の高まりと、改善された患者ケアソリューションに対する需要の高まりによって推進されています。さらに、シリコーンやポリウレタンなどの生体適合性材料の進歩は、長期カテーテル挿入に耐久性と快適性を提供することで、この傾向をさらに後押ししています。医療施設や在宅ケア提供者が患者の安全を優先するにつれて、これらの革新が市場の成長を後押しし、高度な留置カテーテルオプションがより広く好まれるようになっています。

レポートの範囲と留置カテーテル市場のセグメンテーション

Indwelling Catheters Market Definition

Indwelling catheters are medical devices inserted into the body to provide continuous access to the bladder for draining urine over an extended period. Unsuch as intermittent catheters that are removed after use, indwelling catheters are designed to remain in place for a longer duration, often days or weeks, depending on medical necessity.

Indwelling Catheters Market Dynamics

Drivers

• Rising Prevalence of Urinary Disorders

The rising prevalence of urinary disorders is a significant driver for the indwelling catheters market. For instance, according to the National Kidney Foundation, approximately 37 million people in the U.S. alone suffer from chronic kidney disease (CKD), a condition that often necessitates catheterization for effective management. In addition, studies indicate that about 25% of adults aged 65 and older experience urinary incontinence, highlighting the growing demand for catheter indwelling in the aging population. As these conditions increase, medical professionals rely more on indwelling catheters to provide essential care and maintain quality of life for patients. The rising burden of urinary disorders, coupled with advancements in catheter technology aimed at reducing complications such as infections, fuels the market's expansion and underlines the importance of indwelling catheters as a vital medical solution.

• Increasing Number of Surgical Procedures

The increasing number of surgical procedures, particularly in urology and gynecology, is a key driver for the growth of the indwelling catheters market. For instance, the World Health Organization (WHO) reports that global surgical procedures are expected to surpass 300 million annually, with a significant proportion related to urological and gynecological surgeries where catheter use is essential for post-operative care. In urology, procedures such as prostatectomy and bladder surgeries frequently require catheterization for urine drainage and healing support. Similarly, in gynecology, surgeries such as hysterectomy and pelvic procedures often necessitate the use of indwelling catheters to manage urinary function post-surgery. This growing demand for catheters in post-surgical recovery emphasizes their importance in ensuring patient comfort and preventing complications, further boosting the market for indwelling catheters.

Opportunities

• Increasing Advancements in Catheter Technology

Advancements in catheter technology are significantly driving the adoption of indwelling catheters, presenting a notable market opportunity. Innovations such as antimicrobial coatings, which actively inhibit bacterial growth, and biocompatible materials that minimize adverse reactions are enhancing the safety profile of these medical devices. For instance, catheters coated with silver alloy or hydrophilic coatings have been shown to reduce catheter-associated urinary tract infections (CAUTIs) by up to 50%, improving patient outcomes and hospital safety. In addition, improved designs that include features such as anti-reflux mechanisms and soft, flexible structures contribute to greater patient comfort and ease of use. Such technological enhancements address key concerns in catheter care, including infection risk and patient discomfort, thereby driving increased use in hospitals and clinical settings. These innovations make indwelling catheters more reliable and appealing to healthcare providers, supporting their adoption and fostering growth within the market.

• Enhancing Healthcare Infrastructure

Enhancing healthcare infrastructure, particularly in developing regions, is driving the growth of the indwelling catheters market by improving accessibility and usage. For instance, initiatives by governments and private sectors to build new hospitals, clinics, and specialized medical centers in emerging economies such as India and Southeast Asian countries have significantly increased the demand for medical supplies, including indwelling catheters. With better healthcare facilities, more patients can receive timely treatments and post-surgical care that requires the use of catheters for urinary management. Furthermore, investments in medical technology and training for healthcare providers are ensuring that these facilities can effectively utilize modern catheter solutions, which are vital for patient care in various medical scenarios. This progress is opening opportunities for manufacturers to expand their reach and develop region-specific products that meet local healthcare needs, making the expansion of healthcare infrastructure a key market driver for indwelling catheters.

Restraints/Challenges

• Involved Infection and Complications

Infection and complications are significant challenges in the indwelling catheters market, as the risk of associated infections, particularly catheter-associated urinary tract infections (CAUTIs), can lead to severe health complications, extended hospital stays, and increased healthcare costs. CAUTIs, for instance, are among the most common healthcare-associated infections, posing a serious risk to patients and contributing to morbidity and mortality, especially in vulnerable populations such as the elderly and those with compromised immune systems. To address this, manufacturers are investing in the development of advanced catheters with antimicrobial coatings or materials that can help reduce the risk of infection and improve patient outcomes. However, these advanced features can lead to increased production costs and complexity, making the final product more expensive. This added expense can limit widespread adoption, particularly in healthcare facilities with tight budgets or in regions with limited resources. The challenge of balancing effective infection prevention with affordability and accessibility underscores the need for continuous innovation, cost-effective manufacturing, and strategic partnerships to ensure that these safer products reach a broader patient base.

• Complex Regulatory Requirements

Regulatory requirements pose a significant challenge in the indwelling catheters market, as manufacturers must navigate strict standards set by regulatory bodies such as the FDA in the United States and CE in Europe to ensure the safety, quality, and efficacy of their products. Compliance with these regulations often involves detailed documentation, rigorous testing, and the submission of clinical trial data, which can be both time-consuming and costly. For instance, the FDA's approval process for new medical devices requires manufacturers to demonstrate substantial evidence of a product's safety and performance through comprehensive pre-market submissions, which can take months or even years to complete. This complex and resource-intensive process can be particularly burdensome for smaller companies that may lack the financial capacity or technical expertise needed to meet these stringent requirements. Failure to comply can result in delayed product launches, fines, or even the inability to market the product, which can hinder a company's ability to compete effectively in the market. The challenge of navigating regulatory compliance highlights the importance of investing in regulatory expertise and adopting proactive strategies to manage the demands of global standards to maintain market viability and patient safety.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Indwelling Catheters Market Scope

The market is segmented on the basis of type, material, coating type, and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• 2-way Catheters
• 3-way Catheters
• 4-way Catheters

Material

• Latex
• Silicone

Coating Type

• Hydrogel Coating
• Silver Alloy Coating
• Silicone-elastomer
• Others

Application

• Post-surgical Care
• Critical Care
• Urinary Incontinence
• Benign Prostate Hyperplasia

Indwelling Catheters Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, type, material, coating type, and application as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the indwelling catheters market, driven by the high prevalence of various related health conditions, including urinary bladder disorders and kidney failures. The region benefits from advanced healthcare infrastructure, access to cutting-edge medical technology, and a robust network of medical professionals specializing in urology and nephrology. In addition, the increasing awareness and availability of medical treatments contribute to the market's growth. This dominant position is reinforced by ongoing research and the adoption of innovative catheter technologies to improve patient care and outcomes.

Asia-Pacific is projected to experience the highest growth rate in the indwelling catheters market from 2025 to 2032, driven by the region's rapidly increasing population and a rising incidence of urological conditions. The region’s expanding healthcare infrastructure and improvements in medical technology are contributing to better access to treatment options. In addition, governments and private sectors are investing in healthcare advancements, enhancing medical care quality and availability. These factors combined are fostering the growth of the indwelling catheters market in Asia-Pacific.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Indwelling Catheters Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Indwelling Catheters Market Leaders Operating in the Market Are:

• Centurial (U.S.)
• Cardinal Health (U.S.)
• B. Braun SE (Germany)
• BD (U.S.)
• Coloplast Group (Denmark)
• Teleflex Incorporated (U.S.)
• Cook (U.S.)
• Medline Industries, Inc. (U.S.)
• SunMed (U.S.)
• Amsino International, Inc. (U.S.)
• Poiesis Medical LLC (U.S.)
• Ribbel International Limited (U.K.)
• Sterimed Group (India)
• 3M (U.S.)
• CompactCath Inc. (U.S.)
• Convatec Inc. (U.K.)
• TE Connectivity (Switzerland)
• Hangzhou Fushan Medical Appliances Co., LTD (China)
• CURE MEDICAL, LLC (U.S.)
• HR HealthCare, Inc. (U.S.)

Latest Developments in Indwelling Catheters Market

• In July 2024, the Hyderabad-based startup Mexple, known for its innovative personal medical products, introduced the UroMen and UroWomen urine collection kits designed for males and females in the incontinence category. These new kits are set to transform patient care by offering advanced design, comfort, and functionality, meeting a significant need in home medical care
• 2024年4月、メドライン社とコンシュアメディカル社は、カテーテル関連尿路感染症（CAUTI）と失禁関連皮膚炎（IAD）のリスクを軽減することを目的とした男性用外用尿管理装置QiVi MECの独占販売代理店としてメドライン社と提携することを発表しました。
• 2023年2月、コロプラストは尿路感染症のリスクを軽減するために開発された男性用カテーテル「ルジャ」を発売しました。この新製品により、コロプラストの製品ラインナップが拡充され、市場での存在感が強化されると期待されています。
• 2023年1月、スマート尿道（フォーリー）カテーテル固定装置の革新的な開発企業であるCATHETRIXは、アラブヘルス2023でカテーテルスタビライザーを発表しました。フォーリー/セーフスタビライザーは、カテーテルを切断し、保持バルーンを収縮させ、損傷を最小限に抑えることで膀胱と尿道を保護し、フォーリーカテーテルの偶発的な抜去を防ぐように設計された最初の装置です。
• 2020年4月、BACTIGUARD ABは、継続的な体温モニタリングが重要な集中治療室や外科手術室の患者向けに設計されたBIP Foley TempSensor尿道カテーテルを発売しました。

SKU-65442